| RS2543059779 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2543059971 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2543060389 |
GPHN
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2543061332 |
SIN3A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2543061756 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS2543061981 |
SIN3A
|
Health Risk |
Likely pathogenic |
SIN3A-related disorder, SIN3A-related disorder |
| RS2543062387 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2543062487 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2543064634 |
DICER1
|
Health Risk |
Likely pathogenic |
Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS2543065306 |
WDR72
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta hypomaturation type 2A3, Amelogenesis imperfecta hypomaturation type 2A3 |
| RS2543067973 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS2543069732 |
DMXL2
|
Health Risk |
Pathogenic |
— |
| RS2543070545 |
WDR72
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS2543072613 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS2543075783 |
SIN3A
|
Health Risk |
Likely pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |
| RS2543076155 |
SIN3A
|
Health Risk |
Pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |
| RS2543076887 |
SIN3A
|
Health Risk |
Likely pathogenic |
SIN3A-related intellectual disability syndrome, SIN3A-related intellectual disability syndrome |
| RS2543078313 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS2543082930 |
PIGB
|
Health Risk |
Pathogenic |
— |
| RS2543084151 |
TUBGCP4
|
Health Risk |
Likely pathogenic |
— |
| RS2543089023 |
PIGB
|
Health Risk |
Likely pathogenic |
— |
| RS2543093050 |
ATP8A2
|
Health Risk |
Pathogenic |
— |
| RS2543107879 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS2543110485 |
SYNM
|
Health Risk |
Conflicting classifications of pathogenicity |
SYNM-related disorder, SYNM-related disorder |
| RS2543112047 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS2543114978 |
SYNM
|
Health Risk |
Conflicting classifications of pathogenicity |
SYNM-related disorder, SYNM-related disorder |
| RS2543115957 |
UNC45A
|
Health Risk |
Likely pathogenic |
Osteootohepatoenteric syndrome, Osteootohepatoenteric syndrome |
| RS2543117482 |
SYNM
|
Health Risk |
Conflicting classifications of pathogenicity |
SYNM-related disorder, SYNM-related disorder |
| RS2543139833 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2543140344 |
GRIN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2543140979 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2543141007 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2543143325 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2543144045 |
PIGB
|
Health Risk |
Pathogenic |
— |
| RS2543144178 |
PIGB
|
Health Risk |
Pathogenic |
— |
| RS2543152118 |
KIAA0586
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS2543152585 |
KIAA0586
|
Health Risk |
Pathogenic |
KIAA0586-related disorder, KIAA0586-related disorder |
| RS2543155958 |
UNC45A
|
Health Risk |
Pathogenic |
Osteootohepatoenteric syndrome, Osteootohepatoenteric syndrome |
| RS2543159855 |
TRPM1
|
Health Risk |
Pathogenic |
— |
| RS2543159863 |
TRPM1
|
Health Risk |
Pathogenic |
— |
| RS2543161072 |
ERCC4
|
Health Risk |
Pathogenic |
Cockayne syndrome, Xeroderma pigmentosum |
| RS2543161364 |
ERCC4
|
Health Risk |
Pathogenic |
Cockayne syndrome, Xeroderma pigmentosum |
| RS2543163481 |
TRPM1
|
Health Risk |
Pathogenic |
— |
| RS2543164636 |
MADD
|
Health Risk |
Likely pathogenic |
Deeah syndrome, Deeah syndrome |
| RS2543165272 |
KNL1
|
Health Risk |
Likely pathogenic |
Microcephaly 4, primary |
| RS2543169545 |
ERCC4
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group F |
| RS2543174139 |
ERCC4
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group Q, Xeroderma pigmentosum |
| RS2543177794 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2543178404 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2543178455 |
DICER1
|
Health Risk |
Likely pathogenic |
Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome, Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome |
| RS2543179169 |
DICER1
|
Health Risk |
Pathogenic |
— |
| RS2543179894 |
ERCC4
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, Xeroderma pigmentosum |
| RS2543179941 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2543180159 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2543180252 |
ERCC4
|
Health Risk |
Pathogenic |
— |
| RS2543180436 |
DICER1
|
Health Risk |
Likely pathogenic |
Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome, Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome |
| RS2543182907 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, DICER1-related tumor predisposition |
| RS2543184108 |
ERCC4
|
Health Risk |
Likely pathogenic |
— |
| RS2543186334 |
UNC45A
|
Health Risk |
Pathogenic |
Osteootohepatoenteric syndrome, Osteootohepatoenteric syndrome |
| RS2543187534 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2543187841 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2543188305 |
DICER1
|
Health Risk |
Likely pathogenic |
Pleuropulmonary blastoma, Pleuropulmonary blastoma |
| RS2543227368 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2543228849 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2543228908 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, DICER1-related tumor predisposition |
| RS2543230737 |
DICER1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2543230821 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2543252133 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543252248 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543252284 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543252304 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543253078 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543253145 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543253237 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543253260 |
NR2E3
|
Health Risk |
Likely pathogenic |
NR2E3-related disorder, NR2E3-related disorder |
| RS2543253289 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543253358 |
NR2E3
|
Health Risk |
Pathogenic/Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543253366 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543253382 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543253698 |
NR2E3
|
Health Risk |
Likely pathogenic |
— |
| RS2543253786 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543253848 |
NR2E3
|
Health Risk |
Pathogenic/Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543254013 |
NR2E3
|
Health Risk |
Likely pathogenic |
— |
| RS2543254025 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543254082 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543254294 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543254412 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543254453 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543254500 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Retinitis pigmentosa 37 |
| RS2543254818 |
NR2E3
|
Health Risk |
Pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543254872 |
NR2E3
|
Health Risk |
Pathogenic/Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543256115 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543256122 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543256174 |
NR2E3
|
Health Risk |
Pathogenic/Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543256250 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543256322 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543256622 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543257167 |
NR2E3
|
Health Risk |
Pathogenic |
— |
| RS2543257393 |
NR2E3
|
Health Risk |
Conflicting classifications of pathogenicity |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS2543260820 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |